Higher app engagement was associated with greater weight loss
That said, both medications are FDA-approved, effective treatments for obesity and type 2 diabetes and the ideal choice depends on individual patient factors
Beta blockers: Can reduce energy expenditure and blunt fat burning
The following peptides are promising for combination with Semaglutide: Insulin-sensitizing peptides (e.g., analogs of GLP-1, GIP, or related peptides) may complement semaglutides glucose-lowering effects
At the FDAs request, Novo Nordisk has organized a study to analyze complications related to Wegovy in pregnancies that already happened, and a registry that will prospectively follow the health outcomes of a group of people exposed to Wegovy during pregnancy compared to pregnant people who werent
L., Calanna, S., Davies, M., Van Gaal, L